- Automation of radiopharmaceutical chemistry especially where related to 15O, 18F and 11C syntheses for clinical uses.
- In vivo Imaging in particular (PET) and it’s combination with simultaneous Magnetic Resonance Imaging (MRI) commonly referred to PET/MR.
- The validation of molecular imaging techniques directed towards disease detection and management.
- PET Imaging centre design, construction, equipping and commissioning.
What is your vision of the future of radiochemistry/radiopharmacy/nuclear medicine?
Not great due to increasing regulatory constraints and associated costs in the translation of preclinical imaging research with novel molecular imaging probes into man.
What is your opinion on why young researcher should choose nuclear medicine as their research discipline?
Provides excellent opportunities to join, and learn from, working in interdisciplinary teams.
Do you have encouraging advice for young researchers to succeed in the world of science?
Don’t stop learning!
Who inspired you to choose this field/science?